Literature DB >> 8550833

A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.

Q Lin1, J Rohrer, R C Allen, M Larché, J M Greene, A O Shigeoka, R A Gatti, D C Derauf, J W Belmont, M E Conley.   

Abstract

Mutations in the gene for CD40 ligand are responsible for the X-linked form of hyper IgM syndrome. However, no clinical or laboratory findings that reliably distinguish X-linked disease from other forms of hyper IgM syndrome have been reported, nor are there tests available that can be used to confidently provide carrier detection. To identify efficiently mutations in the gene for CD40 ligand, eight pairs of PCR primers that could be used to screen genomic DNA by single strand conformation polymorphism (SSCP) were designed. 11 different mutations were found in DNA from all 13 patients whose activated T cells failed to bind a recombinant CD40 construct. The exact nature of four of these mutations, a deletion and three splice defects, could not be determined by cDNA sequencing. In addition, SSCP analysis permitted rapid carrier detection in two families in whom the source of the mutation was most likely a male with gonadal chimerism who passed the disorder on to some but not all of his daughters. These studies document the utility of SSCP analysis for both mutation detection and carrier detection in X-linked hyper IgM syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550833      PMCID: PMC507079          DOI: 10.1172/JCI118389

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Dinucleotide repeat polymorphism in the human CD40 ligand gene.

Authors:  R C Allen; M K Spriggs; J W Belmont
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

2.  Mapping of the X linked form of hyper IgM syndrome (HIGM1)

Authors:  M Padayachee; R J Levinsky; C Kinnon; A Finn; C McKeown; C Feighery; L D Notarangelo; R W Hendriks; A P Read; S Malcolm
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

3.  Factor VIII gene explains all cases of haemophilia A.

Authors:  J A Naylor; P M Green; C R Rizza; F Giannelli
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

4.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

5.  Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.

Authors:  R J Armitage; B M Macduff; M K Spriggs; W C Fanslow
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

6.  A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors.

Authors:  M C Peitsch; C V Jongeneel
Journal:  Int Immunol       Date:  1993-02       Impact factor: 4.823

7.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

9.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

Authors:  D Hollenbaugh; L S Grosmaire; C D Kullas; N J Chalupny; S Braesch-Andersen; R J Noelle; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  13 in total

1.  A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions.

Authors:  B Barnhart; G S Ford; A Bhushan; C Song; L R Covey
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

Review 3.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

4.  First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.

Authors:  Otavio Cabral-Marques; Stefanie Klaver; Lena F Schimke; Évelyn H Ascendino; Taj Ali Khan; Paulo Vítor Soeiro Pereira; Angela Falcai; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Liliana Bezrodnik; Ileana Moreira; Gisela Seminario; Daniela Di Giovanni; Andrea Gómez Raccio; Oscar Porras; Cristina Worm Weber; Janaíra Fernandes Ferreira; Fabiola Scancetti Tavares; Elisa de Carvalho; Claudia França Cavalcante Valente; Gisele Kuntze; Miguel Galicchio; Alejandra King; Nelson Augusto Rosário-Filho; Milena Baptistella Grota; Maria Marluce dos Santos Vilela; Regina Sumiko Watanabe Di Gesu; Simone Lima; Leiva de Souza Moura; Eduardo Talesnik; Eli Mansour; Pérsio Roxo-Junior; Juan Carlos Aldave; Ekaterine Goudouris; Fernanda Pinto-Mariz; Laura Berrón-Ruiz; Tamara Staines-Boone; Wilmer O Córdova Calderón; María del Carmen Zarate-Hernández; Anete S Grumach; Ricardo Sorensen; Anne Durandy; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Francisco Espinosa-Rosales; Hans D Ochs; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

5.  Clinical application of whole-genome sequencing in patients with primary immunodeficiency.

Authors:  Talal Mousallem; Thomas J Urban; K Melodi McSweeney; Sarah E Kleinstein; Mingfu Zhu; Mehdi Adeli; Roberta E Parrott; Joseph L Roberts; Brian Krueger; Rebecca H Buckley; David B Goldstein
Journal:  J Allergy Clin Immunol       Date:  2015-05-14       Impact factor: 10.793

6.  Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.

Authors:  M L Prasad; M Velickovic; S A Weston; E M Benson
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

7.  Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM.

Authors:  K C Gilmour; D Walshe; S Heath; G Monaghan; S Loughlin; T Lester; G Norbury; C M Cale
Journal:  Mol Pathol       Date:  2003-10

8.  Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.

Authors:  Asghar Aghamohammadi; Nima Parvaneh; Nima Rezaei; Kasra Moazzami; Sara Kashef; Hassan Abolhassani; Amir Imanzadeh; Javad Mohammadi; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2009-07-03       Impact factor: 8.317

Review 9.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

10.  A mutation in X-linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific T cells.

Authors:  E Lopez-Granados; M Stacey; A-K Kienzler; S Sierro; C B Willberg; C P Fox; S Rigaud; H M Long; A D Hislop; A B Rickinson; S Patel; S Latour; P Klenerman; H Chapel
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.